Loss of the expression and localization of inhibin α-subunit in high grade prostate cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 3, 1998, Pages 969-975

  Mellor, Sally L ^a   Richards, Michelle G ^a   Pedersen, John S ^b   Robertson, David M ^a   Risbridger, Gail P ^a,c  

^a MONASH MEDICAL CENTRE   (Australia)

^b MELBOURNE PATHOLOGY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN A; MESSENGER RNA;

ARTICLE; BASAL CELL; CANCER GRADING; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INHIBINS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0031764969     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.3.969     Document Type: Article

References (43)

1. Burger HG, Findlay JK, Robertson DM. 1996 Inhibin/activin/follistatin. In: Adashi EY, Rock JA, Rosenwak Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott Raven; 802-806.
2. Rivier C, Rivier J, Vale WW. 1986 Inhibin-mediated feedback control of follicle stimulating hormone secretion in the female rat. Science. 234:205-208.
3. Steinberger A, Steinberger E. 1976 Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology. 99:918-921.
4. Erickson GF, Hsueh AJW. 1978 Secretion of inhibin by rat granulosa cells in vitro. Endocrinology. 103:1960-1961.
5. Ling N, Ying S-Y, Ueno N, et al. 1986 Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature. 321:779-782.
6. Robertson D, Burger HG, Sullivan J, et al. 1996 Biological and immunological characterisation or inhibin forms in human plasma. J Clin Endocrinol Metab. 81:669-676.
7. Robertson D, Sullivan J, Watson M, Cahir N. 1994 Forms of inhibin: biological and immunological characterisation. In: Burger HG, Findlay J, Robertson D, de Kretser D, Petraglia F, eds. Inhibin and inhibin related proteins. Rome: Ares-Serono Symposia; 25-32.
8. Findlay JK, Russell DL, Doughton B, Tsonis CG, Borchers C, Forage RG. 1994 Effect of active immunization against the amino-terminal peptide (αN) of the alpha 43 kDa subunit of inhibin (α43) on fertility of ewes. Reprod Fertil Dev. 6:265-267.
9. Matzuk MM, Finegola MJ, Su JG, Hsueh AJ, Bradley A. 1992 Alpha inhibin is a tumor suppressive gene with gonadal specificity in mice. Nature. 360:313-319.
10. Matzuk MM, Finegola MJ, Mather JP, Krummen L, Lu H, Bradley A. 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA. 91:8817-8821.
11. Kanen K, Karkkula M, El-Hefnawy T, et al. 1996 The mouse inhibin α-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice. Mol Cell Endocrinol. 119:135-146.
12. Healy DL, Burger HG, Mamers P, et al. 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours. N Engl J Med. 329:1539-1541.
13. Jobling T, Mamers P, Healy DL, et al. 1994 A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol. 55:285-289.
14. Gurusinghe CJ, Healy DL, Jobling T, Mamers F, Burger HG. 1995 Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol. 57:27-32.
15. Batres Y, Zhang Z, Ying S-Y. 1995 Expression of activins and activin receptor messenger RNAs in LNCaP cells, a human prostatic adenocarcinoma cell line. Int J Oncol. 6:1185-1188.
16. Ying S-Y, Zhang Z, Xing W. 1995 Expression of activin and activin receptors in PC3 human prostatic tumor cell lines. Int J Oncol. 6:601-606.
17. Furst BA, Zhang Z, Ying S-Y. 1995 Expression of activin and activin receptors in human prostatic carcinoma cell line DU145. Int J Oncol. 7:239-243.
18. Thomas TZ, Chapman SM, Wang H, et al. 1998 Inhibins, activins and follistatins: expression of mRNAs and cellular localisation in tissues from men with benign prostatic hyperplasia. Prostate. 34:34-43.
19. Robertson DM, Cahir N, Findlay JK, Burger HG, Groome N. 1997 The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma. J Clin Endocrinol Metab. 82:889-896.
20. Findlay JK, Tsonis CG, Doughton B, et al. 1989 Immunization against the amino-terminal peptide (αN) of the alpha 43 subunit of inhibin impairs fertility in sheep. Endocrinology. 124:3122-3124.
21. Esch FS, Shimasaki S, Cooksey K, et al. 1987 Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol Endocrinol. 1:388-396.
22. Mason AJ, Niall HD, Seeburg PH. 1986 Structure of two human ovarian inhibins. Biochem Biophys Res Commun. 135:957-964.
23. Mostofi FK, Davis CJ, Sesterhenn IA. 1993 Histopathology of prostate cancer. In: Lepor H, Lawson, RK, eds. Prostate diseases. Philadelphia: Saunders; 229-256.
24. Bonkhoff H, Stein U, Remberger K. 1994 The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 24:114-118.
25. Nishihara T, Okahashi N, Ueda N. 1993 Activin A induces apoptotic cell death. Biochem Biophys Res Commun. 192:985-991.
26. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP. 1990 Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology. 127:3196-3205.
27. van Dissel-Emiliani FMF, Grootenhuis AJ, de Jong FH, de Fooji DG. 1989 Inhibin reduces spermatogonial numbers in the testes of adult mice and Chinese hamsters. Endocrinology. 125:1898-1903.
28. Mather JP, Attie KM, Woodruff T, Rice GC, Phillips DM. 1990 Activin stimulates spermatogonial proliferation in germ-Sertoli cell co-cultures from immature rat. Endocrinology. 127:3206-3214.
29. 3H)thymidine incorporation by rat thymocytes and 3T3 fibroblasts in vitro. Mol Cel Endocrinol. 61:133-138.
30. Bonkhoff H, and Remberger K. 1996 Differential pathways and histogenic aspects of normal and abnormal prostatic growth: a stem cell model Prostate. 28:98-106.
31. Anawalt BD, Bebb RA, Matsumoto AM, et al. 1996 Serum inhihin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 81:3341-3345.
32. Illingworth PJ, Groome NP, Byrd W, et al. 1996 Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab. 81:1321-1325.
33. C chaim. Biochem Biophys. Res. Commun. 206:608-613.
34. McPherson SJ, Thomas TZ Wang H, Gurusinghe CJ, Risbridger GP. 1997 Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol. 154:535-545.
35. Manning A, Williams A, Game S, Paraskeva C. 1991 Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGFβ) conversion of an adenoma cell line to a tumorogenic phenotype is accompanied by a reduced response to the inhibitory effects of TGFβ. Oncogene. 6:1471-1476.
36. Myeroff LL, Parsons R, Kim S-J, et al. 1995 A TGF-beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:5545-5547.
37. Parsons R, Myeroff LL, Liu B, et al. 1995 Microsatellite instability and mutations of the TGF-β type II receptor gene in colorectal cancer. Cancer Res 55:5548-5550.
38. Laiho M, Weis F, Massague J. 1990 Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem. 265:18518-18524.
39. Markowitz S, Wang J, Myeroff L, et al. 1995 Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1336-1338.
40. Markowitz SD, Roberts AB. 1996 Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:93-102.
41. Woodruff TK, Borree J, Attie N, Cox ET, Rice GC, Mather JP. 1992 Stage specific binding of inhibin to subpopulations of rat germ cells. Endocrinology. 130:871-881.
42. Krummen LA, Moore A, Woodruff TK, et al. 1994 Localisation of inhibin and activin binding sites in the testis during development by in situ ligand binding. Biol Reprod. 50:734-744.
43. Thomas TZ, Wang H, Niclasen P, et al. 1997 Expression and localisation of activin subunits and follistatins in tissues from men with high grade cancer. J Clin Endocrinol Metab. 82:3851-3858.